My Blog

Tag: Model Answer

  • [Solved] nursing theories week 1

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering nursing theories week 1.

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] Week 2 RES709

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    [>Management homework help](https://www.sweetstudy.com/fields/business-finance-management) As a scholar, practitioner, and leader in research design, you will need to be able to identify research terms and the concepts associated with basic and applied research. The difference between applied and ba…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    [>Management homework help](https://www.sweetstudy.com/fields/business-finance-management)

    As a scholar, practitioner, and leader in research design, you will need to be able to identify research terms and the concepts associated with basic and applied research.

    The difference between applied and basic research is necessary to develop a practical research study. The difference between basic research and applied research lies in their respective aims.

    – Basic research refers to acquiring new, fundamental knowledge and theoretical understanding of basic human and other natural processes without any particular application in view.
    – Applied research is also conducted as an original investigation to acquire new knowledge, but it is primarily directed toward practical objectives to provide relatively immediate solutions.

    ##### Assessment Deliverable

    This assignment has two parts. Complete Parts 1 and 2 below.

    Part 1: Article Analysis

    Locate an applied research article on a topic in your program of study (e.g., DBA, DHA, DM, EDD) from the [University Library](https://library.phoenix.edu/home).

    Review the qualitative and quantitative research designs in the CDS Dissertation Guide on [CDS Central](https://www.phoenix.edu/doctoral-studies.html) to familiarize yourself with different applied designs.

    _Note_: Keywords to use while searching for an article in the library might include action research, program evaluation, etc.

    Write a 350- to 525-word analysis about what makes the study discussed in the article applied versus basic research and do the following:

    – *Identify the article topic (e.g., education, business, health care) and provide a link to the article.
    – *Explain how the study in the article addresses a real-world, practical problem.
    – *Explain how the study results could impact people’s lives, work, health, and/or general well-being.
    – Part 2: Access and Permission Considerations

    An integral aspect of choosing a topic is access or the ability to conduct your study. For example, you may want to know how leaders in a particular company use social media to increase sales, but they are unwilling to talk to you. If you cannot gain access to the leaders, then you will not be able to gather the data you need for your study.

    Additionally, when selecting a topic for your study, consider whether conducting the study would involve talking to protected classes of people or vulnerable populations. Federal regulations require protecting the welfare of vulnerable subjects who may not be of age, have the authority or ability to speak for themselves, or are vulnerable in any other way.

    Protected classes include the following:

    – Children or minors under the age of 18
    – Prisoners
    – Pregnant women
    – People with cognitive impairments or mental disabilities
    – People who are educationally or economically disadvantaged

    _Note:_ If you are considering conducting research with any of the protected classes of human subjects, consider options for completing your study differently. For example, talk to the minor children’s parents, instead of talking to the minor children. There are many creative options!

    Write a 350- to 525-word summary in which you:

    – *Identify what permissions you will need to access the people, organizations, and/or data to conduct your research.
    – *Identify who you might need to consult to gain permission to conduct your study.
    – *Explain what potential issues you might encounter.
    – *Explain how you may address these potential issues.

    Compile Part 1 and Part 2 into one document for submission.

    Format in-text citations and references according to current APA guidelines.

    _Reminder:_ Before submitting your assessment, proofread for grammar and sentence structure, re-read the assignment directions, and refer to the Summative Assessment rubric to ensure each element of the assignment has been addressed.

    – ##### Assessment Support

    – For a well-structured scholarly paragraph, please refer to the Paragraphing with the MEAL Plan section in Appendix B of the [CSD Student Paper template](https://multimedia.phoenix.edu/cms/202124567). Use the template to also ensure proper APA formatting.
    – Use the APA Tutorials within the [Doctoral Writing Resources](https://multimedia.phoenix.edu/cms/doctoral-writing-resources) and format your paper according to APA guidelines.
    – Review the [grading rubric](https://multimedia.phoenix.edu/cms/202550188) for guidance on deliverable expectations.
    – Review the following resources for writing guidelines and APA information:
    – [Center for Writing Excellence](https://multimedia.phoenix.edu/cms/cwe/)
    – [Reference and Citation Generator](https://multimedia.phoenix.edu/cms/citation)
    – [Grammar Assistance](https://multimedia.phoenix.edu/cms/202010168/)

    – [\
    \
    res709_v6_grading_rubrics.pdf](https://www.sweetstudy.com/files/res709-v6-grading-rubrics-pdf "res709_v6_grading_rubrics.pdf")
    – [\
    \
    CDS_student_paper_template.docx](https://www.sweetstudy.com/files/cds-student-paper-template-docx-10293983 "CDS_student_paper_template.docx")

    – a year ago

  • [Solved] Nursing assignment 582 week 4

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    Reflect on the mission, vision, and values of a workplace organization and how the workplace organization addresses a culture of excellence. Note: you may use the same workplace organization that you discussed in this week's Collaboration Café. (RWJBarnabas Health) Use Canva.com or another platform …

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Reflect on the mission, vision, and values of a workplace organization and how the workplace organization addresses a culture of excellence. Note: you may use the same workplace organization that you discussed in this week's Collaboration Café. (RWJBarnabas Health)

    Use Canva.com or another platform of your choice to create an infographic

    1. Ensure the infographic is readable.
    2. Ensure the infographic is well-organized and easy to follow.
    3. Correctly cite and reference ideas and information that come from scholarly sources of information. Include in-text citations and list references at the bottom of the infographic.
    4. Follow rules of grammar, spelling, word usage, and punctuation consistent with formal, scientific writing.
    5. Abide by Chamberlain University academic integrity policy.
    6. Submit the completed infographic as a PDF or JPG file to the assignment Dropbox.
    7. Submit a screenshot of the completed infographic.
    1. Highlight the date and time your infographic was created as shown in the image below.
    2. The submitted infographic must match the screenshot and reflect the current academic session.

    Include the following sections/headings in the infographic.

    1. Culture of Excellence
    1. Explain the concept of a culture of excellence in healthcare.
    2. Identify three specific organizational characteristics or practices that reflect a culture of excellence and briefly describe each characteristic or practice.
    3. Discuss how a culture of excellence is significant to your selected advanced nursing role in one or two sentences.
    4. Provide support from at least one scholarly source.
    2. Mission, Vision, and Values
    1. Describe the mission, vision, and values of a selected healthcare organization (note: the organization you choose must have all three elements: mission, vision, and values statements).
    2. Explain the interrelationships of the mission, vision, and values in one or two sentences.
    3. Describe how an organization’s mission, vision, values, and organizational structure contribute to organizational culture in one or sentences.
    3. Leading a Culture of Excellence
    1. Describe how the advanced nurse leader can leverage the mission, vision, values, and organizational structure to create positive change in the organizational culture in one or two sentences.
    2. Identify two leadership strategies the advanced nurse leader can use to support a culture of excellence and briefly describe each strategy.
    3. Provide support from at least one scholarly source.

    please provide AI and Similarity report

    – [\
    \
    Screenshot2025-05-15210104.png](https://www.sweetstudy.com/files/screenshot2025-05-15210104-png "Screenshot2025-05-15210104.png")

    – a year ago

  • [Solved] week 2 DB response 2

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    see attachment – a year ago **files (1)** – ## Week2DBresponse2-.pdf **## Week2DBresponse2-.pdf** Table 1 Infection Description Presentation Causes/ Risk Factors Treatment per CDC Addtl info Candida Fungal infection due to candida albicans Pruritic, soreness, dyspareunia , occasionally thick vaginal…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    see attachment

    – a year ago

    **files (1)**

    – ## Week2DBresponse2-.pdf

    **## Week2DBresponse2-.pdf**

    Table 1

    Infection Description Presentation Causes/ Risk
    Factors

    Treatment per
    CDC

    Addtl
    info

    Candida

    Fungal
    infection due
    to candida
    albicans

    Pruritic,
    soreness,
    dyspareunia
    ,
    occasionally
    thick
    vaginal
    discharge
    and dysuria.
    KOH
    demonstrate
    s budding

    Pregnancy,
    immunosupression,
    antibiotic use,
    diabetes

    – Fluconazole 150
    mg single dose

    Not
    usually
    considere
    d an STI.

    BV

    Vaginal
    discharge or
    malodorous in
    childbearing
    people. N

    Mal-
    odorous/
    fishy odor,
    thin gray-
    white
    discharge,
    clue cells on

    sexual activity,
    particularly with
    new or multiple
    partners, the use of
    douching, and not
    using condoms

    Metronidazole 500
    mg BID x 7 days
    OR 0.75% gel x 5
    days

    Not
    sexually
    transmittt
    ed

    Chlamydi
    a

    STI caused by
    Chlamydia
    trachomatis

    Often
    Asymptoma
    tic;
    cervicitis,
    urethritis,
    dysuria,
    postcoital
    bleeding

    having multiple or
    new sexual
    partners, not using
    condoms during
    sex, and having a
    history of other
    STIs

    Doxycycline 100
    mg BID x 7 days
    (preferred); or
    Azithromycin 1 g
    PO x1

    Sexually
    transmitt
    ed;
    screen
    annually

    Gonorrhe
    a

    STI caused by
    Nisseria
    gonorrheae

    Purulent
    discharge,
    pelvic pain,
    dysuria,
    urethritis,
    often
    asymptomat
    ic in women

    unprotected sex,
    having multiple
    sexual partners, a
    history of other
    sexually
    transmitted
    infections (STIs),
    and being a young
    adult (under 25)

    Ceftriaxone 500
    mg IM x1 (if <150
    kg); treat
    Chlamydia
    empirically unless
    ruled out

    Sexually
    transmitt
    ed,
    screen
    annually

    Trichomo
    nas

    STI caused by
    Trichomonas
    vaginalis

    Frothy
    yellow-
    green
    discharge,
    strawberry
    cervix, foul
    odor,

    Multiple partners,
    unprotected sex

    Metronidazole 500
    mg BID x 7 days
    or 2g PO x1

    Sexually
    transmitt
    ed,
    partner
    needs to
    be
    treated

    Cervicitis
    Inflammation
    of cervix due
    to STI

    Mucopurule
    nt
    discharge,
    cervical
    bleeding
    with contact

    Chlamydia,
    Gonorrhea, HSV

    Treat based on
    organism;
    empirically cover
    Chlamydia &
    Gonorrhea

    Can
    cause
    PID if
    not
    treater

    PID

    Ascending
    polymicrobial
    infection of
    upper genital
    tract

    Pelvic pain,
    cervical
    motion
    tenderness,
    fever,
    discharge

    Untreated
    Chlamydia/
    Gonorrhea,
    multiple partners

    Ceftriaxone 500
    mg IM x1 +
    Doxycycline 100
    mg BID x 14d

    Metronidazole

    Risk for
    infertility

    HIV

    Human
    immunodeficie
    ncy virus , a
    virus that
    attacks cells
    that help the
    body fight
    infection.
    Affects the

    Acute: flu-
    like
    symptoms

    Chronic:
    becomes
    opportunisti
    c infection

    Unprotected sex,
    IV drug use, MSM,
    mother-to-child

    ART
    (Antiretroviral
    therapy) – lifelong

    Screenin
    g should
    be
    offered
    annually

    Syphilis
    STI caused by
    treponema
    pallidum

    Primary:
    Painless
    chancre

    Secondary:
    rash on
    palms, soles

    Tertiary:
    neurological
    and cardiac
    involvement

    MSM, HIV+,
    multiple partners,
    unprotected sex

    Benzathine
    penicillin G 2.4M
    units IM x1
    (early); weekly x3
    (late/unknown
    duration)

    Screen
    all
    pregnant
    patients,
    treat
    partners.

    Table 2

    Hep B

    hepatitis B
    virus is a small
    DNA virus that
    belongs to the
    “Hepadnavirid
    ae” family.

    Fatigue,
    jaundice,
    RUQ pain

    Sexual contact, IV
    drug use, perinatal
    transmission,
    healthcare
    exposure

    Supportive care
    (acute); Antivirals
    for chronic (e.g.,
    tenofovir,
    entecavir)

    Screenin
    g done to
    all
    pregnant
    patients,
    vaccine
    available

    Hep C

    Hepatitis C is a
    viral infection
    that causes
    liver swelling,
    called
    inflammation.
    Hepatitis C can
    lead to serious
    liver damage.

    Faituge,
    jaundice

    IV drug use, blood
    transfusions
    (pre-1992), sexual
    exposure

    Direct-acting
    antivirals (e.g.,
    sofosbuvir/
    velpatasvir) for 8–
    12 weeks

    Screen
    adults, no
    vaccine
    available

    HSV

    Herpes
    Simplex Virus.
    Herpes is a
    common virus
    that can cause
    cold sores or
    genital sores. It
    spreads
    through skin-
    to-skin contact

    Painless
    vesciles or
    ulcers,
    dysuria,
    systemic
    symptoms
    during
    primary
    infection

    Oral/genital
    contact,
    unprotected sex,
    vertical
    transmission

    Acyclovir 400 mg
    TID x 7–10 days
    or Valacyclovir 1g
    BID x 7–10 days

    Lifelong
    therapy

    Question Answer

    Name 10 Risk Factors for contracting STI’s
    and HIV

    1. Having unprotected sex

    2. Having multiple partners

    3. Injection of drugs with dirty needle
    sharing.

    4. History of previous STI

    5. Substance use

    6. Sex work or transactional sex

    7. Lac of access to healthcare or education

    8. Not being vaccinated against preventable
    STIs

    9. Being incarcerated or having a partner
    who is

    10.Sexual coercion or violence

    Name 5 safer sex practices

    1. Limiting sexual partners

    2. Regular STI testing, especially with new
    partners

    3. Use condoms every tine you have sex

    4. Avoid sex under the influence of drugs or
    alcohol

    5. Inspect partners for visible sore or
    symptoms

    Can HIV be transmitted through sweat, saliva,
    and tears? (Include rationale)

    No, HIV can be transmitted from one infected
    person to another through blood, semen,
    vaginal secretions, rectal fluids and breast
    milk. For HIV to occur, the HIV in these fluids
    must get into the bloodstream of an HIV-
    negative person through a mucous membrane
    through open cuts or sores, or by direct
    injection.

    Lisa is a 19-year-old female who presents to the clinic c/o abnormal vaginal discharge for one
    week after having unprotected vaginal intercourse with a new male partner she has been dating
    for a couple of weeks. Lisa’s pregnancy test is negative and her LMP was 2 weeks ago. As her
    health care provider, you will need to perform testing to determine if Lisa has contracted a
    sexually transmitted infection or other vaginal infection.

    SOAP NOTE

    Demographic: 19/ Female G0P0

    Subjective

    Chief complain: “abnormal vaginal discharge for one week after having unprotected vaginal
    intercourse with a new male partner that I have been dating for a couple of weeks.”

    Name 2 types of intercourse are at the highest
    risk for contracting HIV

    1. Unprotected vaginal sex

    2. Unprotected anal sex

    Why are women more susceptible to HIV in a
    male to female relationship (versus a male
    contracting it from a female)?

    In women, several factors can increase the risk
    of HIV transmission. For example, during
    vaginal or anal intercourse, women are at
    greater risk of acquiring HIV because
    receptive sex is generally riskier than insertive
    sex. Age-related thinning and dryness of the
    vaginal tissue—common in older women—
    can lead to microtears during intercourse,
    providing a pathway for HIV transmission.
    Biologically, women are more vulnerable to
    infection due to the larger mucosal surface
    area exposed during penile penetration.
    Additionally, young women under the age of
    17 are at even higher risk because they have
    an underdeveloped cervix and produce less
    protective vaginal mucus.

    HPI:

    Lisa is a 19 year ld female G0P0 who presents with a one week history of abnormal discharge
    after having unprotected vaginal intercourse with a new male partner.

    • Onset: one week
    • Locating: vaginal
    • Duration: ongoing
    • Characteristic: abnormal
    • Aggrevating/relieving factors: none stated
    • Treatment: none tried

    HPI questions:

    • Is there any vaginal itching, burning or odor?
    • Are you having any symptoms such as cramping, pelvic pain, fever, burning when you pee?
    • Have you had this type of discharge in the past?
    • When was the last time you were tested for STIs?

    Gyn history:

    • LMP: 2 weeks ago, stated, regular
    • Unknown if on birth control at this time
    • Sexually active, new male partner, no protection
    • No known gynocological issues at this time.

    Medical history

    • No known medical conditions
    • No known surgical conditions
    • No known drug allergies
    • Immunizations: up to date

    Family history:

    • Mother: no known medical history
    • Father: no known medical history
    • Maternal grandmother: no known medical history
    • Paternal grandmother: no known medical history,

    Social history

    • Goes to school

    • Balanced diet
    • Regular exercise
    • No drug or alcohol use
    • Sexual history: one new male partner, no protection
    • Relationship: new

    Other questions

    • Are you in a monogamous relationship?
    • Do you practice safe sex?

    Review of systems:

    • General: healthy, denies fever denies chills
    • Neuro: denies headacces or dizziness
    • Cardiovascular: denies chest pain or palpitations
    • Resp: denies shortness of breaeth or cough
    • GI: denies nausea, vomiting or diarrhea or abdominal pain
    • GU: positive abnormal discharge
    • Skin: denies rash, denies new lesions
    • Health maintenance: No Pap in the last 12 months due to age

    Objective

    Vitals: WNL

    • Temp: 98.6
    • BP: 120/80
    • HR:78
    • RR: 17
    • Heihgt: 5’4”
    • Weight: 135
    • BMI: 23.2

    Physical exam:

    • General: AAOx4, no acute distress
    • abdomen soft, non tender
    • Pelvic:

    o Vulva: normal appearance
    o Vagina: abnormal discharge
    o Cervix: normal
    o Uterus: non tender
    o Adnexa: no masses or tenderness

    POCT

    • Urine pregnancy : negative
    o Rule out pregnancy due to age and no condom use
    • Wet mount with KOH and send out check for chlamydia, gonorrhea, BV, trichomonas
    o KOH to help identify yeast, or bv or trichomonas cells
    • NAAT
    o For STI screening

    Assessment

    Final diagnosis:

    • Vaginal candidiasis B37.3 – clinical presentation of abnormal discharge

    Differential:

    • Bacterial vaginosis N76.0 – due to new sexual partner after unprotected sex
    • Trichomoniasis A59.9 – due to new sexual partner after unprotected sex
    • Chlamydia A56.0 – due to new sexual partner after unprotected sex

    Plan

    Diagnostics:

    • NAAT: Chlamydia, Gonorrhea and trichomonas
    • KOH for BV
    • Serology for HIV, syphilis, Hep B and C
    • Pap smear

    Treatments:

    • Fluconazole 150 mg Po x 1 dose orally

    o This medication is being prescribed at tis time as it is the first line therapy for uncomplicated
    candidiasis, some of the side effects are GI upset, and elevated liver enzymes. This
    medication should not be prescribed if patient has a history of liver disease.

    If STI positive: depending on what STI patient comes back positive for, prescriptions will
    change. Both patient and partner will need to be treated and abstain from sex for a week.

    Patient education:

    • Risk factors for STIs
    • Abstain from sex for 7 days until symptoms have resolved, and medication taken
    • Practice safe sex
    • Refrain from having multiple partners as it can place you at higher risks for HIV andSTIs
    • Routine STI screening

    Complications: if untrearted can causes recurect yeast infectons, risk of spreading infection to
    partner and increased risk for HIV and other STIs.

    Referals: refer to GYN follow up

    Follow up;

    • Office will call when lab results return
    • Follow up in one week if symptoms do not improve
    • Pap smear

    Health maintenance:

    • Pap smear starting at age 21
    • Hpv vaccine
    • STI screening annualy or whena new partner
    • Up to date on vaccines

    **## Week2DBresponse2-.pdf**

    Table 1

    Infection Description Presentation Causes/ Risk
    Factors

    Treatment per
    CDC

    Addtl
    info

    Candida

    Fungal
    infection due
    to candida
    albicans

    Pruritic,
    soreness,
    dyspareunia
    ,
    occasionally
    thick
    vaginal
    discharge
    and dysuria.
    KOH
    demonstrate
    s budding

    Pregnancy,
    immunosupression,
    antibiotic use,
    diabetes

    – Fluconazole 150
    mg single dose

    Not
    usually
    considere
    d an STI.

    BV

    Vaginal
    discharge or
    malodorous in
    childbearing
    people. N

    Mal-
    odorous/
    fishy odor,
    thin gray-
    white
    discharge,
    clue cells on

    sexual activity,
    particularly with
    new or multiple
    partners, the use of
    douching, and not
    using condoms

    Metronidazole 500
    mg BID x 7 days
    OR 0.75% gel x 5
    days

    Not
    sexually
    transmittt
    ed

    Chlamydi
    a

    STI caused by
    Chlamydia
    trachomatis

    Often
    Asymptoma
    tic;
    cervicitis,
    urethritis,
    dysuria,
    postcoital
    bleeding

    having multiple or
    new sexual
    partners, not using
    condoms during
    sex, and having a
    history of other
    STIs

    Doxycycline 100
    mg BID x 7 days
    (preferred); or
    Azithromycin 1 g
    PO x1

    Sexually
    transmitt
    ed;
    screen
    annually

    Gonorrhe
    a

    STI caused by
    Nisseria
    gonorrheae

    Purulent
    discharge,
    pelvic pain,
    dysuria,
    urethritis,
    often
    asymptomat
    ic in women

    unprotected sex,
    having multiple
    sexual partners, a
    history of other
    sexually
    transmitted
    infections (STIs),
    and being a young
    adult (under 25)

    Ceftriaxone 500
    mg IM x1 (if <150
    kg); treat
    Chlamydia
    empirically unless
    ruled out

    Sexually
    transmitt
    ed,
    screen
    annually

    Trichomo
    nas

    STI caused by
    Trichomonas
    vaginalis

    Frothy
    yellow-
    green
    discharge,
    strawberry
    cervix, foul
    odor,

    Multiple partners,
    unprotected sex

    Metronidazole 500
    mg BID x 7 days
    or 2g PO x1

    Sexually
    transmitt
    ed,
    partner
    needs to
    be
    treated

    Cervicitis
    Inflammation
    of cervix due
    to STI

    Mucopurule
    nt
    discharge,
    cervical
    bleeding
    with contact

    Chlamydia,
    Gonorrhea, HSV

    Treat based on
    organism;
    empirically cover
    Chlamydia &
    Gonorrhea

    Can
    cause
    PID if
    not
    treater

    PID

    Ascending
    polymicrobial
    infection of
    upper genital
    tract

    Pelvic pain,
    cervical
    motion
    tenderness,
    fever,
    discharge

    Untreated
    Chlamydia/
    Gonorrhea,
    multiple partners

    Ceftriaxone 500
    mg IM x1 +
    Doxycycline 100
    mg BID x 14d

    Metronidazole

    Risk for
    infertility

    HIV

    Human
    immunodeficie
    ncy virus , a
    virus that
    attacks cells
    that help the
    body fight
    infection.
    Affects the

    Acute: flu-
    like
    symptoms

    Chronic:
    becomes
    opportunisti
    c infection

    Unprotected sex,
    IV drug use, MSM,
    mother-to-child

    ART
    (Antiretroviral
    therapy) – lifelong

    Screenin
    g should
    be
    offered
    annually

    Syphilis
    STI caused by
    treponema
    pallidum

    Primary:
    Painless
    chancre

    Secondary:
    rash on
    palms, soles

    Tertiary:
    neurological
    and cardiac
    involvement

    MSM, HIV+,
    multiple partners,
    unprotected sex

    Benzathine
    penicillin G 2.4M
    units IM x1
    (early); weekly x3
    (late/unknown
    duration)

    Screen
    all
    pregnant
    patients,
    treat
    partners.

    Table 2

    Hep B

    hepatitis B
    virus is a small
    DNA virus that
    belongs to the
    “Hepadnavirid
    ae” family.

    Fatigue,
    jaundice,
    RUQ pain

    Sexual contact, IV
    drug use, perinatal
    transmission,
    healthcare
    exposure

    Supportive care
    (acute); Antivirals
    for chronic (e.g.,
    tenofovir,
    entecavir)

    Screenin
    g done to
    all
    pregnant
    patients,
    vaccine
    available

    Hep C

    Hepatitis C is a
    viral infection
    that causes
    liver swelling,
    called
    inflammation.
    Hepatitis C can
    lead to serious
    liver damage.

    Faituge,
    jaundice

    IV drug use, blood
    transfusions
    (pre-1992), sexual
    exposure

    Direct-acting
    antivirals (e.g.,
    sofosbuvir/
    velpatasvir) for 8–
    12 weeks

    Screen
    adults, no
    vaccine
    available

    HSV

    Herpes
    Simplex Virus.
    Herpes is a
    common virus
    that can cause
    cold sores or
    genital sores. It
    spreads
    through skin-
    to-skin contact

    Painless
    vesciles or
    ulcers,
    dysuria,
    systemic
    symptoms
    during
    primary
    infection

    Oral/genital
    contact,
    unprotected sex,
    vertical
    transmission

    Acyclovir 400 mg
    TID x 7–10 days
    or Valacyclovir 1g
    BID x 7–10 days

    Lifelong
    therapy

    Question Answer

    Name 10 Risk Factors for contracting STI’s
    and HIV

    1. Having unprotected sex

    2. Having multiple partners

    3. Injection of drugs with dirty needle
    sharing.

    4. History of previous STI

    5. Substance use

    6. Sex work or transactional sex

    7. Lac of access to healthcare or education

    8. Not being vaccinated against preventable
    STIs

    9. Being incarcerated or having a partner
    who is

    10.Sexual coercion or violence

    Name 5 safer sex practices

    1. Limiting sexual partners

    2. Regular STI testing, especially with new
    partners

    3. Use condoms every tine you have sex

    4. Avoid sex under the influence of drugs or
    alcohol

    5. Inspect partners for visible sore or
    symptoms

    Can HIV be transmitted through sweat, saliva,
    and tears? (Include rationale)

    No, HIV can be transmitted from one infected
    person to another through blood, semen,
    vaginal secretions, rectal fluids and breast
    milk. For HIV to occur, the HIV in these fluids
    must get into the bloodstream of an HIV-
    negative person through a mucous membrane
    through open cuts or sores, or by direct
    injection.

    Lisa is a 19-year-old female who presents to the clinic c/o abnormal vaginal discharge for one
    week after having unprotected vaginal intercourse with a new male partner she has been dating
    for a couple of weeks. Lisa’s pregnancy test is negative and her LMP was 2 weeks ago. As her
    health care provider, you will need to perform testing to determine if Lisa has contracted a
    sexually transmitted infection or other vaginal infection.

    SOAP NOTE

    Demographic: 19/ Female G0P0

    Subjective

    Chief complain: “abnormal vaginal discharge for one week after having unprotected vaginal
    intercourse with a new male partner that I have been dating for a couple of weeks.”

    Name 2 types of intercourse are at the highest
    risk for contracting HIV

    1. Unprotected vaginal sex

    2. Unprotected anal sex

    Why are women more susceptible to HIV in a
    male to female relationship (versus a male
    contracting it from a female)?

    In women, several factors can increase the risk
    of HIV transmission. For example, during
    vaginal or anal intercourse, women are at
    greater risk of acquiring HIV because
    receptive sex is generally riskier than insertive
    sex. Age-related thinning and dryness of the
    vaginal tissue—common in older women—
    can lead to microtears during intercourse,
    providing a pathway for HIV transmission.
    Biologically, women are more vulnerable to
    infection due to the larger mucosal surface
    area exposed during penile penetration.
    Additionally, young women under the age of
    17 are at even higher risk because they have
    an underdeveloped cervix and produce less
    protective vaginal mucus.

    HPI:

    Lisa is a 19 year ld female G0P0 who presents with a one week history of abnormal discharge
    after having unprotected vaginal intercourse with a new male partner.

    • Onset: one week
    • Locating: vaginal
    • Duration: ongoing
    • Characteristic: abnormal
    • Aggrevating/relieving factors: none stated
    • Treatment: none tried

    HPI questions:

    • Is there any vaginal itching, burning or odor?
    • Are you having any symptoms such as cramping, pelvic pain, fever, burning when you pee?
    • Have you had this type of discharge in the past?
    • When was the last time you were tested for STIs?

    Gyn history:

    • LMP: 2 weeks ago, stated, regular
    • Unknown if on birth control at this time
    • Sexually active, new male partner, no protection
    • No known gynocological issues at this time.

    Medical history

    • No known medical conditions
    • No known surgical conditions
    • No known drug allergies
    • Immunizations: up to date

    Family history:

    • Mother: no known medical history
    • Father: no known medical history
    • Maternal grandmother: no known medical history
    • Paternal grandmother: no known medical history,

    Social history

    • Goes to school

    • Balanced diet
    • Regular exercise
    • No drug or alcohol use
    • Sexual history: one new male partner, no protection
    • Relationship: new

    Other questions

    • Are you in a monogamous relationship?
    • Do you practice safe sex?

    Review of systems:

    • General: healthy, denies fever denies chills
    • Neuro: denies headacces or dizziness
    • Cardiovascular: denies chest pain or palpitations
    • Resp: denies shortness of breaeth or cough
    • GI: denies nausea, vomiting or diarrhea or abdominal pain
    • GU: positive abnormal discharge
    • Skin: denies rash, denies new lesions
    • Health maintenance: No Pap in the last 12 months due to age

    Objective

    Vitals: WNL

    • Temp: 98.6
    • BP: 120/80
    • HR:78
    • RR: 17
    • Heihgt: 5’4”
    • Weight: 135
    • BMI: 23.2

    Physical exam:

    • General: AAOx4, no acute distress
    • abdomen soft, non tender
    • Pelvic:

    o Vulva: normal appearance
    o Vagina: abnormal discharge
    o Cervix: normal
    o Uterus: non tender
    o Adnexa: no masses or tenderness

    POCT

    • Urine pregnancy : negative
    o Rule out pregnancy due to age and no condom use
    • Wet mount with KOH and send out check for chlamydia, gonorrhea, BV, trichomonas
    o KOH to help identify yeast, or bv or trichomonas cells
    • NAAT
    o For STI screening

    Assessment

    Final diagnosis:

    • Vaginal candidiasis B37.3 – clinical presentation of abnormal discharge

    Differential:

    • Bacterial vaginosis N76.0 – due to new sexual partner after unprotected sex
    • Trichomoniasis A59.9 – due to new sexual partner after unprotected sex
    • Chlamydia A56.0 – due to new sexual partner after unprotected sex

    Plan

    Diagnostics:

    • NAAT: Chlamydia, Gonorrhea and trichomonas
    • KOH for BV
    • Serology for HIV, syphilis, Hep B and C
    • Pap smear

    Treatments:

    • Fluconazole 150 mg Po x 1 dose orally

    o This medication is being prescribed at tis time as it is the first line therapy for uncomplicated
    candidiasis, some of the side effects are GI upset, and elevated liver enzymes. This
    medication should not be prescribed if patient has a history of liver disease.

    If STI positive: depending on what STI patient comes back positive for, prescriptions will
    change. Both patient and partner will need to be treated and abstain from sex for a week.

    Patient education:

    • Risk factors for STIs
    • Abstain from sex for 7 days until symptoms have resolved, and medication taken
    • Practice safe sex
    • Refrain from having multiple partners as it can place you at higher risks for HIV andSTIs
    • Routine STI screening

    Complications: if untrearted can causes recurect yeast infectons, risk of spreading infection to
    partner and increased risk for HIV and other STIs.

    Referals: refer to GYN follow up

    Follow up;

    • Office will call when lab results return
    • Follow up in one week if symptoms do not improve
    • Pap smear

    Health maintenance:

    • Pap smear starting at age 21
    • Hpv vaccine
    • STI screening annualy or whena new partner
    • Up to date on vaccines

  • [Solved] week 2 DB response

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    see attachment – a year ago **files (1)** – ## Week2DBresponse–.pdf **## Week2DBresponse–.pdf** Infe ctio n Description Presentation Causes/Risk Factors Treatment per CDC Additional Info Can dida Fungal infection (yeast) Vulvar itching, thick white discharge Antibiotics use, diabetes, pregnancy, t…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    see attachment

    – a year ago

    **files (1)**

    – ## Week2DBresponse–.pdf

    **## Week2DBresponse–.pdf**

    Infe
    ctio
    n

    Description Presentation
    Causes/Risk

    Factors
    Treatment per

    CDC Additional Info

    Can
    dida

    Fungal
    infection
    (yeast)

    Vulvar
    itching, thick
    white
    discharge

    Antibiotics use,
    diabetes,
    pregnancy, tight
    clothes

    Fluconazole
    150 mg PO
    single dose

    Not sexually
    transmitted

    BV
    Bacterial
    vaginosis

    Thin gray
    discharge,
    fishy odor

    Douching,
    multiple partners,
    new sex partner

    Metronidazole
    500 mg PO
    BID x 7 days

    Not an STI, but
    related to sexual
    activity

    Chl
    amy
    dia

    Bacterial STI

    Often
    asymptomatic,
    discharge,
    dysuria

    Unprotected sex,
    <25 yrs, multiple
    partners

    Doxycycline
    100 mg BID x
    7 days

    Screen all
    sexually active
    females <25

    Gon
    orrh
    ea

    Bacterial STI
    Purulent
    discharge,
    pelvic pain

    Same as
    chlamydia

    Ceftriaxone
    500 mg IM +
    doxycycline

    Often co-infected
    with chlamydia

    Tric
    hom
    onas

    Protozoan
    STI

    Frothy
    yellow-green
    discharge,
    odor

    Unprotected sex,
    multiple partners

    Metronidazole
    2g PO single
    dose

    Treat both
    partners

    Cer
    vicit
    is

    Inflammation
    of cervix
    often due to
    STI

    Bleeding,
    discharge,
    pelvic pain

    Chlamydia,
    gonorrhea

    Treat based on
    causative
    organism

    Can lead to PID

    PID

    Infection of
    upper
    reproductive
    tract

    Pelvic pain,
    fever, cervical
    motion pain

    Untreated STIs
    Ceftriaxone +
    doxycycline +
    metronidazole

    Risk for
    infertility

    HIV

    Virus
    affecting
    immune
    system

    Fever, fatigue,
    weight loss

    Needle sharing,
    sex, mother-to-
    child

    Antiretroviral
    therapy (ART)

    Lifelong
    management

    Syp
    hilis

    Bacterial STI
    (Treponema
    pallidum)

    Chancre, rash,
    systemic
    symptoms

    Sexual contact
    with infected
    person

    Penicillin G
    benzathine IM

    Multiple stages;
    test with RPR/
    VDRL

    Table 2: STI Knowledge Questions

    SOAP Note – Tina, 27-year-old Female

    Subjective:

    Chief Complaint (CC):
    “My vagina is burning, and I have painful blisters.”

    HPI (OLDCARTS):

    Hep
    B

    Liver
    infection due
    to HBV

    Fatigue,
    jaundice,
    nausea

    Sexual contact,
    needle use

    Supportive,
    antivirals for
    chronic cases

    Vaccine available

    Hep
    C

    Liver
    infection due
    to HCV

    Often
    asymptomatic,
    may cause
    fatigue

    Blood-to-blood
    contact, needle
    sharing

    Direct-acting
    antivirals
    (DAAs)

    No vaccine;
    chronic if
    untreated

    HS
    V

    Herpes
    simplex virus
    (type 1 or 2)

    Painful
    vesicles/
    ulcers, fever

    Sexual contact
    Acyclovir,
    Valacyclovir

    Recurrent; no
    cure, only
    symptom
    management

    Question Answer

    Name 10 Risk Factors for
    contracting STIs and HIV

    Unprotected sex, multiple partners, new partner, age <25,
    MSM, history of STIs, drug use, sex work, inconsistent
    condom use, partner with STI

    Name 5 safer sex practices
    Use condoms, limit partners, regular testing, mutual
    monogamy, avoid sex under influence

    Can HIV be transmitted
    through sweat, saliva, and
    tears?

    No. HIV is not transmitted through sweat, saliva, or tears due
    to insufficient viral load

    Name 2 types of intercourse at
    highest risk for contracting
    HIV

    Anal sex (receptive), vaginal sex (receptive)

    Why are women more
    susceptible to HIV in male-to-
    female transmission?

    Larger mucosal surface area exposed, higher viral load in
    semen, potential microtears during sex

    • The patient presented with a C/C of vaginal burning and painful blisters that began 3 days
    ago. The area of concern is in her left labia minora. The patient describes that blisters as
    painful and having a burning sensation with visible fluid-filled vesicles. Friction, urination,
    and tight clothing worsen the pain. The patient describes relief with cool compresses, and
    loose clothing. The discomfort is constant with intermittent sharp pain. She rates the pain a
    6/10.

    Medical History:

    • no previous medical history

    • no known allergies to drugs, food, or environmental factors

    • no recent illnesses or hospitalizations

    • vaccinations are up to date

    Surgical History:

    • No prior surgical history

    Social History:

    • #2 sexual partners in the last 6–12 months

    • Use of protection (condoms)

    • Tobacco, alcohol, recreational drug use, x2 a month socially

    • sexual practices (oral, vaginal, anal)

    Medications:

    • Currently not on any medication

    Allergies:

    • NKDA (No Known Drug Allergies)

    Objective:

    Vital Signs:

    • Temp: 98.6°F

    • HR: 76 bpm

    • BP: 112/70

    • RR: 16/min

    • SpO₂: 98% RA

    Physical Exam:

    • Genital Exam: Multiple small grouped vesicles on an erythematous base noted on the left
    labia minora, tender to palpation. No foul-smelling discharge. No cervical motion tenderness.
    No inguinal lymphadenopathy.

    • Other Systems: Normal

    Point of Care Testing (POCT):

    • HSV PCR swab from lesion: High sensitivity and specificity for HSV-1 and HSV-2 (CDC,
    2021)

    • HIV rapid test: Recommended for new STI evaluation

    • Urine NAAT for gonorrhea and chlamydia: Evaluate for co-infections

    • Syphilis RPR and Hepatitis B/C screening: Per CDC recommendations for STI screening

    Assessment/Diagnosis:

    Presumptive Diagnosis:

    • Genital Herpes Simplex Virus (HSV) Infection – ICD-10: A60.9

    Rationale:

    • Classic presentation of painful, fluid-filled vesicles on erythematous base, localized on labia
    minora, recent unprotected sex, no previous known episodes.

    Differential Diagnoses:

    1. Contact Dermatitis: Less likely—symptoms typically bilateral and not vesicular.

    2. Chancroid: Rare in the U.S.; painful ulcers with ragged borders, not grouped vesicles.

    3. Syphilis (Primary): Typically a painless chancre; not vesicular.

    Plan:

    Pharmacologic Treatment (Assuming HSV PCR Positive):

    • Acyclovir 400 mg tablet PO TID for 10 days

    Patient Education:

    • Medication Use: Take all medication as prescribed, even if symptoms improve early.

    • Side Effects: May include nausea, headache, dizziness.

    • Transmission: Avoid sexual activity until lesions are fully healed. HSV can be transmitted
    even when asymptomatic.

    • Safe Sex: Use condoms consistently to reduce recurrence transmission risk.

    • Partner Notification: Partners should be informed and may need testing.

    • Chronic Management: Discuss suppressive therapy if recurrences occur frequently (>6/
    year).

    Non-Pharmacologic Management:

    • Keep area clean and dry.

    • Use sitz baths and loose clothing.

    • Apply cool compresses to soothe discomfort.

    Follow-Up:

    • Return to clinic in 1–2 weeks or sooner if symptoms worsen.

    • Retesting or management for other STI test results as they return.

    Complications of Non-Treatment:

    • Increased risk of HIV transmission

    • Severe and prolonged outbreaks, especially in immunocompromised patients

    • Psychological distress

    • Neonatal HSV transmission risk in future pregnancies

    – Table 2: STI Knowledge Questions
    – SOAP Note – Tina, 27-year-old Female
    – Subjective:
    – Objective:
    – Assessment/Diagnosis:
    – Plan:
    – Pharmacologic Treatment (Assuming HSV PCR Positive):
    – Patient Education:
    – Non-Pharmacologic Management:
    – Follow-Up:
    – Complications of Non-Treatment:

    **## Week2DBresponse–.pdf**

    Infe
    ctio
    n

    Description Presentation
    Causes/Risk

    Factors
    Treatment per

    CDC Additional Info

    Can
    dida

    Fungal
    infection
    (yeast)

    Vulvar
    itching, thick
    white
    discharge

    Antibiotics use,
    diabetes,
    pregnancy, tight
    clothes

    Fluconazole
    150 mg PO
    single dose

    Not sexually
    transmitted

    BV
    Bacterial
    vaginosis

    Thin gray
    discharge,
    fishy odor

    Douching,
    multiple partners,
    new sex partner

    Metronidazole
    500 mg PO
    BID x 7 days

    Not an STI, but
    related to sexual
    activity

    Chl
    amy
    dia

    Bacterial STI

    Often
    asymptomatic,
    discharge,
    dysuria

    Unprotected sex,
    <25 yrs, multiple
    partners

    Doxycycline
    100 mg BID x
    7 days

    Screen all
    sexually active
    females <25

    Gon
    orrh
    ea

    Bacterial STI
    Purulent
    discharge,
    pelvic pain

    Same as
    chlamydia

    Ceftriaxone
    500 mg IM +
    doxycycline

    Often co-infected
    with chlamydia

    Tric
    hom
    onas

    Protozoan
    STI

    Frothy
    yellow-green
    discharge,
    odor

    Unprotected sex,
    multiple partners

    Metronidazole
    2g PO single
    dose

    Treat both
    partners

    Cer
    vicit
    is

    Inflammation
    of cervix
    often due to
    STI

    Bleeding,
    discharge,
    pelvic pain

    Chlamydia,
    gonorrhea

    Treat based on
    causative
    organism

    Can lead to PID

    PID

    Infection of
    upper
    reproductive
    tract

    Pelvic pain,
    fever, cervical
    motion pain

    Untreated STIs
    Ceftriaxone +
    doxycycline +
    metronidazole

    Risk for
    infertility

    HIV

    Virus
    affecting
    immune
    system

    Fever, fatigue,
    weight loss

    Needle sharing,
    sex, mother-to-
    child

    Antiretroviral
    therapy (ART)

    Lifelong
    management

    Syp
    hilis

    Bacterial STI
    (Treponema
    pallidum)

    Chancre, rash,
    systemic
    symptoms

    Sexual contact
    with infected
    person

    Penicillin G
    benzathine IM

    Multiple stages;
    test with RPR/
    VDRL

    Table 2: STI Knowledge Questions

    SOAP Note – Tina, 27-year-old Female

    Subjective:

    Chief Complaint (CC):
    “My vagina is burning, and I have painful blisters.”

    HPI (OLDCARTS):

    Hep
    B

    Liver
    infection due
    to HBV

    Fatigue,
    jaundice,
    nausea

    Sexual contact,
    needle use

    Supportive,
    antivirals for
    chronic cases

    Vaccine available

    Hep
    C

    Liver
    infection due
    to HCV

    Often
    asymptomatic,
    may cause
    fatigue

    Blood-to-blood
    contact, needle
    sharing

    Direct-acting
    antivirals
    (DAAs)

    No vaccine;
    chronic if
    untreated

    HS
    V

    Herpes
    simplex virus
    (type 1 or 2)

    Painful
    vesicles/
    ulcers, fever

    Sexual contact
    Acyclovir,
    Valacyclovir

    Recurrent; no
    cure, only
    symptom
    management

    Question Answer

    Name 10 Risk Factors for
    contracting STIs and HIV

    Unprotected sex, multiple partners, new partner, age <25,
    MSM, history of STIs, drug use, sex work, inconsistent
    condom use, partner with STI

    Name 5 safer sex practices
    Use condoms, limit partners, regular testing, mutual
    monogamy, avoid sex under influence

    Can HIV be transmitted
    through sweat, saliva, and
    tears?

    No. HIV is not transmitted through sweat, saliva, or tears due
    to insufficient viral load

    Name 2 types of intercourse at
    highest risk for contracting
    HIV

    Anal sex (receptive), vaginal sex (receptive)

    Why are women more
    susceptible to HIV in male-to-
    female transmission?

    Larger mucosal surface area exposed, higher viral load in
    semen, potential microtears during sex

    • The patient presented with a C/C of vaginal burning and painful blisters that began 3 days
    ago. The area of concern is in her left labia minora. The patient describes that blisters as
    painful and having a burning sensation with visible fluid-filled vesicles. Friction, urination,
    and tight clothing worsen the pain. The patient describes relief with cool compresses, and
    loose clothing. The discomfort is constant with intermittent sharp pain. She rates the pain a
    6/10.

    Medical History:

    • no previous medical history

    • no known allergies to drugs, food, or environmental factors

    • no recent illnesses or hospitalizations

    • vaccinations are up to date

    Surgical History:

    • No prior surgical history

    Social History:

    • #2 sexual partners in the last 6–12 months

    • Use of protection (condoms)

    • Tobacco, alcohol, recreational drug use, x2 a month socially

    • sexual practices (oral, vaginal, anal)

    Medications:

    • Currently not on any medication

    Allergies:

    • NKDA (No Known Drug Allergies)

    Objective:

    Vital Signs:

    • Temp: 98.6°F

    • HR: 76 bpm

    • BP: 112/70

    • RR: 16/min

    • SpO₂: 98% RA

    Physical Exam:

    • Genital Exam: Multiple small grouped vesicles on an erythematous base noted on the left
    labia minora, tender to palpation. No foul-smelling discharge. No cervical motion tenderness.
    No inguinal lymphadenopathy.

    • Other Systems: Normal

    Point of Care Testing (POCT):

    • HSV PCR swab from lesion: High sensitivity and specificity for HSV-1 and HSV-2 (CDC,
    2021)

    • HIV rapid test: Recommended for new STI evaluation

    • Urine NAAT for gonorrhea and chlamydia: Evaluate for co-infections

    • Syphilis RPR and Hepatitis B/C screening: Per CDC recommendations for STI screening

    Assessment/Diagnosis:

    Presumptive Diagnosis:

    • Genital Herpes Simplex Virus (HSV) Infection – ICD-10: A60.9

    Rationale:

    • Classic presentation of painful, fluid-filled vesicles on erythematous base, localized on labia
    minora, recent unprotected sex, no previous known episodes.

    Differential Diagnoses:

    1. Contact Dermatitis: Less likely—symptoms typically bilateral and not vesicular.

    2. Chancroid: Rare in the U.S.; painful ulcers with ragged borders, not grouped vesicles.

    3. Syphilis (Primary): Typically a painless chancre; not vesicular.

    Plan:

    Pharmacologic Treatment (Assuming HSV PCR Positive):

    • Acyclovir 400 mg tablet PO TID for 10 days

    Patient Education:

    • Medication Use: Take all medication as prescribed, even if symptoms improve early.

    • Side Effects: May include nausea, headache, dizziness.

    • Transmission: Avoid sexual activity until lesions are fully healed. HSV can be transmitted
    even when asymptomatic.

    • Safe Sex: Use condoms consistently to reduce recurrence transmission risk.

    • Partner Notification: Partners should be informed and may need testing.

    • Chronic Management: Discuss suppressive therapy if recurrences occur frequently (>6/
    year).

    Non-Pharmacologic Management:

    • Keep area clean and dry.

    • Use sitz baths and loose clothing.

    • Apply cool compresses to soothe discomfort.

    Follow-Up:

    • Return to clinic in 1–2 weeks or sooner if symptoms worsen.

    • Retesting or management for other STI test results as they return.

    Complications of Non-Treatment:

    • Increased risk of HIV transmission

    • Severe and prolonged outbreaks, especially in immunocompromised patients

    • Psychological distress

    • Neonatal HSV transmission risk in future pregnancies

    – Table 2: STI Knowledge Questions
    – SOAP Note – Tina, 27-year-old Female
    – Subjective:
    – Objective:
    – Assessment/Diagnosis:
    – Plan:
    – Pharmacologic Treatment (Assuming HSV PCR Positive):
    – Patient Education:
    – Non-Pharmacologic Management:
    – Follow-Up:
    – Complications of Non-Treatment:

  • [Solved] W-DISC 3

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    PLEASE SEE ATTACHED DOCUMENT FOR INSTRUCTIONS AND REQUIREMENT DUE DATE MAY 18, 2025 NO PALGIO MORE THAN 10% 400 WORDS MINIMUM – [\ \ DISCUSSION.docx](https://www.sweetstudy.com/files/discussion-docx-10293873 "DISCUSSION.docx") – a year ago

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    PLEASE SEE ATTACHED DOCUMENT FOR INSTRUCTIONS AND REQUIREMENT

    DUE DATE MAY 18, 2025

    NO PALGIO MORE THAN 10%

    400 WORDS MINIMUM

    – [\
    \
    DISCUSSION.docx](https://www.sweetstudy.com/files/discussion-docx-10293873 "DISCUSSION.docx")

    – a year ago

  • [Solved] TQM Customer Focus

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    [>Management homework help](https://www.sweetstudy.com/fields/business-finance-management) – Describe what you see as three of the challenges facing the director of a large-size hospital today in providing a true customer focus to its operations. Be sure to respond to at least one of your classmates…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    [>Management homework help](https://www.sweetstudy.com/fields/business-finance-management)

    – Describe what you see as three of the challenges facing the director of a large-size hospital today in providing a true customer focus to its operations.

    Be sure to respond to at least one of your classmates' posts. Cite any resources used.

    – a year ago

  • [Solved] Summarize why you believe this nursing practice problem (pressure injury) is an issue in your current or past area of practice.

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering Summarize why you believe this nursing practice problem (pressure injury) is an issue in your current or past area of practice..

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] Summarize why you believe this nursing practice (pressure injury) problem is an issue in your current or past area of practice.

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    In-depth study guidance and analytical solution covering Summarize why you believe this nursing practice (pressure injury) problem is an issue in your current or past area of practice..

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    Full assignment prompt and step-by-step guidance are included in the downloadable solution file.

  • [Solved] smoke in the air

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    understanding how smoke work – a year ago

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    understanding how smoke work

    – a year ago